No Detail Found!

Median survival time of patients after transcatheter chemo-embolization for hepatocellular carcinoma

Author(s)
Zishan Haider Department of Radiology, The Aga Khan University Hospital, Karachi. Pakistan.
Tanveerul Haq Department of Radiology, The Aga Khan University Hospital, Karachi. Pakistan.
Khalid Munir Department of Radiology, The Aga Khan University Hospital, Karachi. Pakistan.
M. Uzair Usman Department of Radiology, The Aga Khan University Hospital, Karachi. Pakistan.
Muhammad Azeemuddin Department of Radiology, The Aga Khan University Hospital, Karachi. Pakistan.
Abstract
Objective: To determine the effect on survival after transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma (HCC). Design: Longitudinal cohort study. Place and Duration of Study: Radiology Department, The Aga Khan University Hospital, Stadium Road, Karachi, from December 1997 to September 2005. Patients and Methods: Patients undergoing TACE procedure for HCC were prospectively followed. Fortythree patients were enrolled from December 1997 to March 2003 in the study and subjected to chemoembolization therapy. Eight out of 43 patients were excluded from the study, who lost to follow-up. All the patients were followed till their death. Median and mean survival were calculated. Results: The median survival of these 35 patients was 410 days (13.6 months), with 95% confidence interval (236 days lower bound and 536 days upper bound). Mean survival time was 603 days (20.1 months) with 95% confidence interval (394 days lower bound and 812 days upper bound). There was significant difference in mean survival time (in days) by Child`s Pugh class (c2 = 12.384; df=2, pvalue= 0.002). Conclusion: The study showed that TACE is an effective palliative treatment. TACE increases the median survival time.
Publication Details
Page(s) 265-269
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 16, Issue: 4, Year: 2006

Request the full text from PASTIC

Keywords
Hepatocellular carcinoma (HCC). Transarterial chemoembolization (TACE) survival time.
References
.1993 .. ncer, 72 : 1557-63.
.1986 .. igDis Sci, 31(9 suppl)) : 133S-46S.
'AgostinoHB, D .1995 .SolinasA. AmJ Roentgenol, 164 : 1165-7.
Rose DM . .. , : .
.2003 .Spectrumof hepatocellulacrarcinoma MeranzeS. Islamabad.J Ayub Med Coll primarytreatmenfotrhepatocellulacrarcinomaA.m J Surg, 15(4) : 405-10.
Marcos-AlvareAz RL .1996 .Okuda K, TaborE. rch Sug, 131 : 292-8.
Rizzi PM .1996 .. MetivierE. Chemoembolizationwithlipoidol anddoxorubicina:pplicabilitiny Britisphatientwsithhepatocellular carcinomaG.ut, 38 : 125-8.
Celi A .1995 .. Efficacyof transartetraiarlgetetdreatmenotnssurvivaol f patients withhepatocellulacrarcinomaa:n ItalianexperienceC.ancer, 75 : 2427-34.
.1995 .A comparisonof lipoidol chemoembolizationand conservative treatmenftor unresectablheepatocellularcarcinomaG.roup d'EtudeetdeTraitemendtu CarcinomeHepatocellulairNee. wEngj Med, 332 : 1256-61.
Okuda K,Tomimatsu M,Okazaki N .1985 .. Naturahlistoroyf hepatocellulacrarcinomaand prognosisin relationtotreatmenstt:udyof 850 patientsC.ancer, 56 : 819-28.
Ink O .1990 .. A randomizedtriaolf hepaticarteriaclhemoembolizationin patientswith unresectablheepatocellularcarcinomaJ. Hepatol, 11 : 181-4.
Angiolini C .1997 .PagliaroL. nn Oncol, 8 : 117-36.
.1998 .BeaugrandM. Intra-arterial chemoembolizationin patientswith hepatocellulacrarcinoma. Hepatogastroenterology, 45 : 1242-7.
Rossi C .2001 .BernardMi. Gastroenterol, 32 : 383-9.
Ayuso MC .1998 .etal. Transartereiamlbolizationversussymptomatictreatmenitn patientswithadvancedhepatocellulacrarcinomar:esultsof a randomizedc, ontrolletdriainl a singleinstitutioHne. patology, 27 : 1578-83.
Weiss AM ,Pflumio F .1996 .Comparison of resection,liver transplantatioand transcathetoeilyr chemoembolizationin the treatmenotf hepatocellulacrarcinomJaH. epatol, 24 : 293-300.
ADMOS .1992 .withCDPP in thetreatmeonfthepatocellulacrarcinoma 33. StuarKtE, AnandAJ, JenkinsRL. Hepatocellulacrarcinomian the 3b1y(siunptprl):aS-a6r5-tSe8r.iinaj elction. Cancer Chemotber Pharmacol, : s2t21ic7fe-a22t.
0

Citations

0

Downloads

93

Views